Lipid Metabolism and Diabetes

Patients with polygenic disorder often show abnormal lipid profiles as a result of hormone regulates several steps of lipid metabolism. Patients those with Type1 diabetes exhibit adequate glycaemic control but do not have quantitative lipoprotein abnormalities, but those exhibit qualitative abnormalities, primarily an increase in smaller, more atherogenic very low‐density lipoprotein (VLDL) particles. Moreover, in the study of diabetes, and Diabetes Control & Complications Trial(DCCT), both group of patients with type1 diabetes were characterised by consistent weight gain, exhibited more lipid profiles in Type2 diabetes (T2D). Dyslipidaemia in Type2 diabetes is characterised by many strictly linked abnormalities: a significant decrease in high‐density lipoprotein (HDL) cholesterol, elevated fasting and postprandial triglycerides (TG), and an increase in smaller low‐density lipoprotein (LDL) and high density lipoprotein (HDL) particles.

  • Diabetes Control and Complications
  • Hyperglycemia and insulin resistance
  • Dyslipidemia

Related Conference of Lipid Metabolism and Diabetes

September 16-17, 2019

International Conference on Diabetes and Heart diseases

Athens, Greece
September 20-21, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
September 20-21, 2019 |

Euro Diabetes Congress & Expo

Prague, Czech Republic
October 23-24, 2019

Annual Summit on Metabolomics

Amsterdam, Netherlands
Nov 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
November 25-26, 2019

Annual Congress on Endocrinology, Diabetes and Healthcare

Bangkok,Thailand
December 02-03, 2019

14th European Diabetes and Endocrinology Congress

| Barcelona, Spain
Diabetes Congress 2019 | December 04-05, 2019 |

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

| Dubai, UAE
January 29-30, 2020

Global Summit On Diabetes & Endocrinology

| Holiday Inn Atrium | Singapore
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan

Lipid Metabolism and Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in